Details for Patent: 9,132,071
✉ Email this page to a colleague
Which drugs does patent 9,132,071 protect, and when does it expire?
Patent 9,132,071 protects VERKAZIA and is included in one NDA.
This patent has forty-three patent family members in eighteen countries.
Summary for Patent: 9,132,071
| Title: | Compositions containing quaternary ammonium compounds |
| Abstract: | Compositions containing quaternary ammonium compounds in which the nitrogen atom is substituted by at least one alkyl group having at least 12 carbon atoms, where composition includes at least 20% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 14 carbon atoms and more than 5%, preferably more than 7% in weight by weight of the total composition, of ammonium halides in which the nitrogen atom is substituted by at least one alkyl group having at least 16 carbon atoms. Ophthalmic oil-in-water emulsions containing such compositions, and the ophthalmic emulsions being are useful for eye care or for the treatment of eye conditions. |
| Inventor(s): | Rabinovich-Guilatt; Laura (Kadima, IL), Lambert; Gregory (Chatenay Malabry, FR), Lallemand; Frederic (Fresnes, FR), Philips; Betty (Antony, FR) |
| Assignee: | SANTEN SAS (Evry, FR) |
| Application Number: | 12/010,778 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 9,132,071
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | VERKAZIA | cyclosporine | EMULSION;OPHTHALMIC | 214965-001 | Jun 23, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 9,132,071
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| 06291236 | Jul 28, 2006 | |
International Family Members for US Patent 9,132,071
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2007278141 | ⤷ Try a Trial | |||
| Canada | 2659322 | ⤷ Try a Trial | |||
| China | 101534791 | ⤷ Try a Trial | |||
| Cyprus | 1114457 | ⤷ Try a Trial | |||
| Cyprus | 1118148 | ⤷ Try a Trial | |||
| Cyprus | 1118436 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
